Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Business & Regulation

Business & Regulation Trends & Forecasts

Video Roundtable: Cell & Gene in a World in Turmoil

| Angus Stewart

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

Business & Regulation Profession

Pharma and Fordism

| Angus Stewart | 10 min read

Sitting Down With… Gen Li, CEO, Phesi

Business & Regulation Trends & Forecasts

Constructing 2022: How Alive Are the Life Sciences?

| Angus Stewart | 3 min read

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?

Business & Regulation Standards & Regulation

Stem Cell Therapy’s Unwelcome Surprise

| Angus Stewart | 9 min read

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

Business & Regulation Digital Technologies

There’s Nothing Artificial About AI’s Potential in Pharma Research

| Avi Kulkarni | 3 min read

Can AI realistically transform data management in pharma? Yes. And it’s already begun.

Business & Regulation Profession

What’s Your Job?

| Angus Stewart | 4 min read

What did switching from client to constructor teach a seasoned biotech professional?

Business & Regulation Business Practice

Imposter Twitter Account Loses Eli Lilly Billions

| Stephanie Sutton | 2 min read

Fake tweet announcing free insulin leads to mayhem.

Business & Regulation Standards & Regulation

Data Discussions

| Stephanie Sutton | 2 min read

How a new working group plans to overcome the problem with in vitro pharmacology data.

Business & Regulation Standards & Regulation

Amazon’s FDA Warning Letters

| Stephanie Sutton | 2 min read

Unregulated drugs being sold and distributed by the online retailer come under fire.

Business & Regulation Standards & Regulation

Why Only a Collective Approach Can Beat Fake Medicine

| Géraldine Lissalde-Bonnet | 5 min read

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register